What actually degrades a peptide.
Why lyophilised powder and reconstituted solution are two different stability problems, the chemistry that breaks peptides down, and which handling choices measurably matter.
Storage advice for research peptides circulates as a set of rules with no reasoning attached: keep it cold, do not shake it, use it within a month. The rules are broadly right, which is why they persist, but stated without mechanism they cannot be applied to a situation nobody wrote a rule for.
This guide covers what is physically happening to a peptide in a vial, which conditions accelerate it, and what a stability window does and does not promise.
Dry and dissolved are different problems
Almost every degradation route that matters for a peptide needs water. Hydrolysis needs it as a reactant. Deamidation proceeds through a hydrated intermediate. Aggregation requires molecules mobile enough in solution to find each other. Removing the water does not merely slow these down; it removes the conditions most of them require.
That is what lyophilisation is for. Freeze-drying leaves a dry, amorphous solid in which the peptide is kinetically trapped and largely unreactive. It is the reason lyophilised material tolerates ambient temperatures in transit, and the reason it is the form research peptides are shipped in.
Reconstitution reverses all of that in one step. The moment bacteriostatic water enters the vial, every water-dependent pathway is available again, and the material moves from a storage problem measured in years to one measured in days or weeks.
Lyophilised
Stable enough for ambient shipping and long-term frozen storage. The limiting factors are moisture ingress through a compromised stopper and, over long periods, oxidation.
In solution
All hydrolytic and conformational routes are live. Refrigeration at 2-8 degrees Celsius slows them; it does not stop them. The usable window is compound-specific and stated on each product page.
The four routes that break peptides down
Degradation is not one process. Knowing which one a given handling mistake accelerates explains why the standard advice takes the shape it does.
Hydrolysis
Water cleaves the peptide backbone, most readily at particular residue pairs and at the extremes of pH. This is the dominant route for peptide in solution and the reason a reconstituted vial has a finite window at all.
Oxidation
Methionine, cysteine and tryptophan residues react with dissolved oxygen, accelerated by light and by trace metal ions. Sequences containing those residues are more vulnerable, which is one reason stability windows differ between compounds that otherwise look similar.
Deamidation
Asparagine and glutamine residues convert to aspartate and glutamate, changing the molecule's charge without breaking the chain. The result can still appear as a peak on a chromatogram while no longer being the intended compound.
Aggregation and adsorption
Peptide molecules associate with one another, or stick to glass and plastic surfaces. Neither is a chemical reaction, but both remove peptide from solution. Agitation drives both by repeatedly exposing molecules to the air-liquid interface.
What measurably changes the rate
The handling rules map onto the mechanisms above. Each of the following is worth doing because of a specific pathway it slows.
- 01
Temperature
Reaction rates fall steeply as temperature drops, which is the entire basis for refrigerating reconstituted vials and freezing lyophilised stock. It is also why a vial left at room temperature between draws loses more of its window than the elapsed time suggests.
- 02
Light
Ultraviolet and visible light drive oxidation of aromatic and sulphur-containing residues. Vials are kept in their carton rather than on an open shelf for this reason alone.
- 03
Agitation
Shaking forces solution through the air-liquid interface repeatedly, where peptide molecules unfold and aggregate. Swirling achieves dissolution without generating that interface, which is why the instruction is always to swirl and never to shake.
- 04
Freeze-thaw cycling
Each cycle concentrates solutes at the advancing ice front and mechanically stresses the peptide. A solution frozen and thawed several times can lose materially more than one held at a stable temperature for the same total duration.
- 05
Contact with the stopper and the needle
Repeated punctures of a vial stopper introduce a route for both microbial and oxygen ingress. This is what a bacteriostatic preservative addresses, and what it does not.
Why the choice of water matters
The diluent is not inert. What is dissolved in it determines whether a vial can be drawn from more than once, and in some cases whether the peptide dissolves at all.
Bacteriostatic water
Contains roughly 0.9% benzyl alcohol, which suppresses microbial growth. That preservative is what makes a multi-draw vial viable, and it is why it is the standard diluent for research peptides supplied in quantities intended for more than one draw.
Sterile water
Sterile at the point of manufacture, with no preservative. A vial reconstituted with it has no defence against organisms introduced at the first puncture, so it is a single-use preparation.
Acetic acid solution
Some peptides are poorly soluble at neutral pH and are supplied with a dilute acetic acid diluent instead. This is a solubility measure, not a preservative one, and it applies only where the product specifies it.
What a preservative does not do
Bacteriostatic means it inhibits microbial growth. It does not sterilise a contaminated solution, and it has no effect at all on the chemical degradation routes above — a vial can be microbiologically sound and chemically well past useful.
Why research peptides ship without refrigeration
A recurring question is whether peptide arriving at ambient temperature has been compromised in transit. For lyophilised material the answer is that ambient shipping is the expected condition rather than a compromise, and the reason is the one this guide opened with: dry peptide lacks the water that most degradation routes require.
This is why material is shipped in the lyophilised state and reconstituted at its destination rather than shipped in solution. The transit window is spent in the form that tolerates it, and the clock on the shorter, temperature-sensitive window only starts once water is added.
None of that makes the lyophilised state indestructible. Prolonged heat still matters, and a vial whose seal has been compromised has admitted moisture regardless of the temperature it travelled at. The check on arrival is the physical state of the vial and stopper, not the temperature of the parcel.
What a stability window is claiming
A stated window is a statement about a rate under specified conditions, not a switch. Material does not become unusable at the end of it and fully potent up until then; it declines continuously, and the window marks where the decline stops being acceptable for the purpose.
Two consequences follow. A vial stored warmer than the stated condition has spent its window faster than the calendar suggests. And a window quoted with no accompanying temperature is not a claim that can be evaluated at all.
Windows are compound-specific because the mechanisms are sequence-specific: a peptide with no methionine, cysteine or tryptophan has no meaningful oxidation route, and one with no asparagine or glutamine does not deamidate. The figure for each compound is stated on its own product page rather than generalised here.
Common questions.
- Does a peptide arriving at room temperature mean it has degraded?
Not for lyophilised material, which is shipped dry precisely because the dry state tolerates ambient transit. Most degradation routes require water, and freeze-drying removes it. The meaningful check on arrival is whether the vial and its stopper are physically intact, since a compromised seal admits moisture regardless of the temperature the parcel travelled at.
- Why does swirling a vial matter more than it sounds like it should?
Shaking repeatedly drives solution through the air-liquid interface, where peptide molecules unfold and aggregate with one another. Aggregation removes peptide from solution without any chemical reaction taking place. Swirling dissolves the powder without generating that interface, which is why the distinction is consistently drawn in handling instructions.
- Does bacteriostatic water prevent a peptide from breaking down chemically?
No. Bacteriostatic water contains benzyl alcohol, which suppresses microbial growth and is what permits a vial to be drawn from more than once. It has no effect on hydrolysis, oxidation or deamidation, so a solution can remain microbiologically sound while the peptide in it has degraded well past usefulness.
- Why do stability windows differ between peptides that look similar?
Because the degradation routes are sequence-specific. Oxidation requires methionine, cysteine or tryptophan residues; deamidation requires asparagine or glutamine. A peptide lacking those residues has no meaningful access to the corresponding route, so two compounds of similar size and use can carry quite different windows.
- Is repeated freezing and thawing worse than continuous refrigeration?
Generally yes for material already in solution. Each freeze-thaw cycle concentrates solutes at the advancing ice front and mechanically stresses the peptide, so several cycles can cost more than holding the same solution at a stable refrigerated temperature for the equivalent total time.
- Can a certificate of analysis confirm a vial is still within its stability window?
No. A certificate reports what one laboratory measured on one sample on the date stated on it, and says nothing about how the material was stored or handled afterwards. Purity at the point of testing and stability in storage are separate questions, and neither is evidence of the other.